- Home
- RCEL vs BZUN Comparison
RCEL vs BZUN Comparison
Compare RCEL & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- BZUN
- Stock Information
- Founded
- RCEL N/A
- BZUN 2007
- Country
- RCEL United States
- BZUN China
- Employees
- RCEL 260
- BZUN N/A
- Industry
- RCEL Medical/Dental Instruments
- BZUN Catalog/Specialty Distribution
- Sector
- RCEL Health Care
- BZUN Consumer Discretionary
- Exchange
- RCEL Nasdaq
- BZUN Nasdaq
- Market Cap
- RCEL 136.7M
- BZUN 144.4M
- IPO Year
- RCEL N/A
- BZUN N/A
- Fundamental
- Price
- RCEL $5.71
- BZUN $2.59
- Analyst Decision
- RCEL Strong Buy
- BZUN Buy
- Analyst Count
- RCEL 4
- BZUN 2
- Target Price
- RCEL $16.50
- BZUN $3.20
- AVG Volume (30 Days)
- RCEL 308.7K
- BZUN 261.0K
- Earning Date
- RCEL 08-07-2025
- BZUN 08-27-2025
- Dividend Yield
- RCEL N/A
- BZUN N/A
- EPS Growth
- RCEL N/A
- BZUN N/A
- EPS
- RCEL N/A
- BZUN N/A
- Revenue
- RCEL $71,661,000.00
- BZUN $1,310,110,798.00
- Revenue This Year
- RCEL $57.16
- BZUN $5.27
- Revenue Next Year
- RCEL $36.69
- BZUN $3.46
- P/E Ratio
- RCEL N/A
- BZUN N/A
- Revenue Growth
- RCEL 41.35
- BZUN 6.77
- 52 Week Low
- RCEL $4.71
- BZUN $2.11
- 52 Week High
- RCEL $14.16
- BZUN $4.38
- Technical
- Relative Strength Index (RSI)
- RCEL 49.89
- BZUN 44.96
- Support Level
- RCEL $5.13
- BZUN $2.56
- Resistance Level
- RCEL $5.87
- BZUN $2.74
- Average True Range (ATR)
- RCEL 0.31
- BZUN 0.12
- MACD
- RCEL 0.14
- BZUN 0.01
- Stochastic Oscillator
- RCEL 83.19
- BZUN 53.46
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About BZUN Baozun Inc.
Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.